[Possibilities of treatment of external pancreatic fistula].

Evaluation of the efficacy of sekretolitičeskoj therapy with synthetic analogue of somatostatin, a short-acting oktreotid (group 1) and extended oktreotid-depo (group 2) in 24 patients with external pancreatic fistulas after destructive pancreatitis. Results of clinical studies have shown that against the backdrop of an analogue of somatostatin-depo true healing and purulent-necrotic pancreatic external fistula occurs in less time: average 19 ± 1.8, and 16.2 ± 1.2 day observations, respectively.
AuthorsD V Cherdantsev, O V Pervova, V Iu Diatlov, D Sh Kurbanov
JournalKhirurgiia (Khirurgiia (Mosk)) Issue 8 Pg. 62-6 ( 2014) ISSN: 0023-1207 [Print] Russia (Federation)
PMID25327679 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Dosage Forms
  • Gastrointestinal Agents
  • Amylases
  • Octreotide
  • Adult
  • Amylases (metabolism)
  • Anti-Bacterial Agents (administration & dosage)
  • Comparative Effectiveness Research
  • Cutaneous Fistula (drug therapy, etiology, metabolism)
  • Dosage Forms
  • Drug Therapy, Combination
  • Female
  • Gastrointestinal Agents (administration & dosage)
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Octreotide (administration & dosage)
  • Pancreas, Exocrine (drug effects, secretion)
  • Pancreatic Fistula (drug therapy, etiology, metabolism)
  • Pancreatitis (complications)
  • Treatment Outcome
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: